Zenas Biopharma Inc (ZBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 60,624 | 40,984 | 39,702 | 27,578 | 0 |
| Operating Income | -55,624 | -40,984 | -39,702 | -27,578 | N/A |
| Other Income | 3,448 | 2,378 | 1,725 | -222 | 0 |
| Pre-tax Income | -52,176 | -38,606 | -37,977 | -27,800 | 0 |
| Net Income Continuous | -52,605 | -38,606 | -37,977 | -27,800 | N/A |
| Net Income | $-52,605 | $-38,606 | $-37,977 | $-27,800 | $N/A |
| EPS Basic Total Ops | 35.25 | -5.02 | -24.23 | -17.89 | N/A |
| EPS Basic Continuous Ops | 35.25 | -5.02 | -24.24 | -17.89 | N/A |
| EPS Diluted Total Ops | 35.25 | -5.02 | -24.23 | -17.89 | N/A |
| EPS Diluted Continuous Ops | 35.25 | -5.02 | -24.24 | -17.89 | N/A |
| EPS Diluted Before Non-Recurring Items | N/A | -5.02 | N/A | N/A | N/A |
| EBITDA(a) | $-60,591 | $-40,948 | $-39,667 | $-27,545 | $N/A |